CLINICAL_TRIALS
trial_result
· 2013-03-13
Clinical Trial Update: Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy [Phase 3]
Summary
Phase 3 trial evaluating intravenous immunoglobulin (10%) for multifocal motor neuropathy has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxalta now part of Shire | Conditions: Multifocal Motor Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2013-03-13